Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lundbeck's experimental Alzheimer's disease drug idalopirdine fails two further late-stage studies

firstwordpharmaFebruary 09, 2017

Tag: idalopirdine , Alzheimer's Disease

PharmaSources Customer Service